These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1973400)

  • 1. [Pharmacological studies of celiprolol: III. Effects of celiprolol on the cardiovascular system and renal function, and its antiarrhythmic effects].
    Ochi S; Kimura Y; Matsuzaki T; Hayashi S; Motonaga A; Tanaka M; Fukui H; Yamazaki A; Matsumura K; Miura A
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):209-27. PubMed ID: 1973400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
    Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiprolol: its profile as a potential antiarrhythmic agent.
    Pruss TP
    Am Heart J; 1988 Nov; 116(5 Pt 2):1412-5. PubMed ID: 2461069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the cardiovascular and pulmonary effects of oral celiprolol, propranolol and placebo in normal volunteers.
    Busst CM; Bush A
    Br J Clin Pharmacol; 1989 Apr; 27(4):405-10. PubMed ID: 2566321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of atenolol on the cardiovascular system (author's transl)].
    Izumi T; Nishimura T; Sakai K; Abiko Y; Hattori Y; Nakaya H; Kanno M
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):505-13. PubMed ID: 6110622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of the antifibrillatory effect of fluorinated derivatives of carazolol and celiprolol: comparison with propranolol.
    Almotrefi AA; Dzimiri N; Aboul-Enein HY; Premkumar LS
    Gen Pharmacol; 1993 May; 24(3):721-5. PubMed ID: 8103496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM; DeLeonardis VM; Hintze TH
    Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
    Smith RD; Cobuzzi A; Wolf PS; Pruss TP
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
    Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol.
    Ishibashi T; Ohta H; Jin H; Mitomi A; Tatebe S; Nakazawa M; Imai S
    Arzneimittelforschung; 1989 Oct; 39(10):1225-8. PubMed ID: 2575385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.